Be part of the knowledge.™

A Doctor's Opinion on Pharma Education

Media Formats

ReachMD Healthcare Image

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Overview
Dr. Daniel Carlat has written in a New York Times article called, “Dr. Drug Rep”, that allowing pharmaceutical companies to sponsor medical education leads to many bad things, including biased education, corrupt physicians, and, ultimately, harm to our patients. Host Dr. Leslie Lundt listens to what he has to say.

Daniel Carlat, MD

Daniel Carlat, MD

Leslie P. Lundt, MD

Leslie P. Lundt, MD

Recommended

Details

Presenters

Overview
Dr. Daniel Carlat has written in a New York Times article called, “Dr. Drug Rep”, that allowing pharmaceutical companies to sponsor medical education leads to many bad things, including biased education, corrupt physicians, and, ultimately, harm to our patients. Host Dr. Leslie Lundt listens to what he has to say.

Daniel Carlat, MD

Daniel Carlat, MD

Leslie P. Lundt, MD

Leslie P. Lundt, MD

Program Chapters

Segment Chapters

Playlist:

Recommended

Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy

Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring

IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base

IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue

IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy

Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies

Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA

Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies